Spots Global Cancer Trial Database for mechanism
Every month we try and update this database with for mechanism cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Mechanism and Process Regulation for Colorectal Tumors | NCT04707482 | Colorectal Canc... Adenoma | 18 Years - 75 Years | Shanghai Minimally Invasive Surgery Center | ||
Mechanism of Action Study for Psoriasis | NCT00932113 | Psoriasis | Methotrexate Adalimumab (Hum... | 18 Years - 85 Years | Tufts Medical Center | |
Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer | NCT05908838 | Gastric Cancer ... | Modified Banxia... combination che... | 17 Years - 75 Years | ShuGuang Hospital | |
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men | NCT05773183 | Hypogonadism, M... Testosterone De... Prostate Cancer Androgen Defici... Metabolic Disea... Metabolic Syndr... Metabolic Distu... Obesity Cardiovascular ... NAFLD Diabetes | Testosterone GnRH | 18 Years - 60 Years | Royal College of Surgeons, Ireland | |
Clinical Study of Weifuchun Treatment on Gastric Cancer | NCT05888675 | Gastric Cancer ... | Weifuchun | 18 Years - 70 Years | ShuGuang Hospital | |
Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer | NCT05908838 | Gastric Cancer ... | Modified Banxia... combination che... | 17 Years - 75 Years | ShuGuang Hospital | |
Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer | NCT03814629 | Chronic Atrophi... | Weifuchun | 18 Years - 70 Years | ShuGuang Hospital | |
Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia | NCT02991066 | Acute Promyeloc... | 18 Years - | First Affiliated Hospital of Harbin Medical University | ||
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations | NCT01726738 | Stage III Melan... Stage IV Melano... Unresectable Me... BRAF Mutant Mel... | BRAF inhibitor ... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men | NCT05773183 | Hypogonadism, M... Testosterone De... Prostate Cancer Androgen Defici... Metabolic Disea... Metabolic Syndr... Metabolic Distu... Obesity Cardiovascular ... NAFLD Diabetes | Testosterone GnRH | 18 Years - 60 Years | Royal College of Surgeons, Ireland | |
Clinical Study of Weifuchun Treatment on Gastric Cancer | NCT05888675 | Gastric Cancer ... | Weifuchun | 18 Years - 70 Years | ShuGuang Hospital | |
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations | NCT01726738 | Stage III Melan... Stage IV Melano... Unresectable Me... BRAF Mutant Mel... | BRAF inhibitor ... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations | NCT01726738 | Stage III Melan... Stage IV Melano... Unresectable Me... BRAF Mutant Mel... | BRAF inhibitor ... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer | NCT03814629 | Chronic Atrophi... | Weifuchun | 18 Years - 70 Years | ShuGuang Hospital |